Market Summary
USD444.38+1.35
Market Closed0.30%
MCK Alerts
MCK Stock Price
MCK RSI Chart
MCK Valuation
MCK Price/Sales (Trailing)
MCK Profitability
MCK Fundamentals
MCK Revenue
MCK Earnings
Price Action
52 Week Range
331.75446.95
(Low)(High)
Last 7 days
2.5%
Last 30 days
4.7%
Last 90 days
6.7%
Trailing 12 Months
29.2%
MCK Financial Health
MCK Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for MCK
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-08 | TYLER BRIAN S. | sold | -10,668,500 | 422 | -25,246 | chief executive officer |
2023-09-06 | TYLER BRIAN S. | sold | -1,602,770 | 407 | -3,938 | chief executive officer |
2023-08-11 | TYLER BRIAN S. | sold | -1,527,240 | 440 | -3,471 | chief executive officer |
2023-08-11 | TYLER BRIAN S. | acquired | 551,889 | 159 | 3,471 | chief executive officer |
2023-08-03 | TYLER BRIAN S. | sold | -1,664,200 | 422 | -3,938 | chief executive officer |
2023-07-21 | KNAUSS DONALD R | acquired | - | - | 773 | - |
2023-07-21 | Mantia Linda Provie | acquired | - | - | 483 | - |
2023-07-21 | Martinez Maria | acquired | - | - | 483 | - |
2023-07-06 | TYLER BRIAN S. | sold | -1,650,060 | 419 | -3,938 | chief executive officer |
2023-06-29 | TYLER BRIAN S. | sold | -1,457,820 | 420 | -3,471 | chief executive officer |
Which funds bought or sold MCK recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-26 | BROOKFIELD Corp /ON/ | reduced | -69.18 | -9,786,000 | 5,745,610 | 0.02% |
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | 3,543 | 21,144 | -% |
2023-09-20 | BARCLAYS PLC | added | 110 | 129,655,000 | 214,768,000 | 0.14% |
2023-09-12 | Farther Finance Advisors, LLC | added | 1.26 | 30,498 | 172,206 | 0.04% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 4,273 | 4,273 | -% |
2023-09-07 | JAG CAPITAL MANAGEMENT, LLC | reduced | -1.2 | 1,062,790 | 6,784,800 | 0.78% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | 285 | 1,710 | -% |
2023-09-05 | Westshore Wealth, LLC | reduced | -5.36 | 30,676 | 256,539 | 0.13% |
2023-08-30 | Western Wealth Management, LLC | reduced | -0.44 | 250,029 | 1,532,740 | 0.13% |
2023-08-25 | EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC | added | 0.42 | 2,468,000 | 14,500,000 | 2.00% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
MCK Alerts
Schedule 13G FIlings of McKesson
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | vanguard group inc | 9.08% | 12,869,151 | SC 13G/A | |
| Feb 03, 2023 | blackrock inc. | 8.3% | 11,784,945 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 10.15% | 15,497,451 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 8.6% | 13,171,252 | SC 13G/A | |
| Feb 16, 2021 | capital ventures international | 0.5% | 865,164 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 10.12% | 16,251,909 | SC 13G/A | |
| Jan 29, 2021 | blackrock inc. | 8.7% | 13,969,975 | SC 13G/A | |
| Oct 13, 2020 | vanguard group inc | 10.17% | 16,496,553 | SC 13G/A | |
| Mar 18, 2020 | capital ventures international | 6.6% | 10,631,600 | SC 13G | |
| Feb 12, 2020 | vanguard group inc | 8.72% | 15,715,599 | SC 13G/A |
Recent SEC filings of McKesson
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 11, 2023 | 4 | Insider Trading | |
| Sep 08, 2023 | 144 | Notice of Insider Sale Intent | |
| Sep 07, 2023 | 4 | Insider Trading | |
| Sep 06, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 14, 2023 | 4 | Insider Trading | |
| Aug 11, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 07, 2023 | 4 | Insider Trading | |
| Aug 03, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 03, 2023 | S-8 | Employee Benefits Plan | |
| Aug 02, 2023 | 10-Q | Quarterly Report |
MCK Fair Value
Loading...
Peers (Alternatives to McKesson)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
UNH | 467.0B | 348.5B | 3.34% | 0.09% | 22.12 | 1.34 | 13.69% | 15.63% |
MCK | 60.2B | 284.0B | 4.66% | 29.21% | 16.06 | 0.21 | 5.81% | 168.62% |
ABC | 36.3B | 254.4B | -3.53% | 22.40% | 21.47 | 0.14 | 7.66% | -8.27% |
CAH | 22.5B | 205.0B | 1.19% | 35.81% | 86.35 | 0.11 | 13.04% | 127.97% |
HSIC | 9.6B | 12.6B | -3.03% | 11.42% | 20.89 | 0.76 | -0.94% | -29.54% |
| MID-CAP | ||||||||
HQY | 6.3B | 937.9M | 8.58% | 4.73% | 493.98 | 6.75 | 17.97% | 120.64% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
AMN | 3.1B | 4.4B | -6.45% | -20.59% | 9.74 | 0.71 | -16.06% | -30.43% |
PDCO | 2.9B | 6.5B | -11.56% | 19.94% | 13.35 | 0.44 | 1.83% | 10.70% |
| SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -13.30% | 52.58% | -145.95 | 1.23 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -5.56% | -8.21% | 25.42 | 1.37 | 10.42% | 21.37% |
OMI | 1.2B | 10.1B | -3.45% | -37.72% | -12.19 | 0.12 | 2.62% | -163.74% |
BKD | 768.0M | 3.0B | -2.86% | -9.13% | -7.45 | 0.26 | 11.66% | -12.20% |
PETQ | 557.4M | 998.8M | -4.59% | 132.73% | -15.14 | 0.56 | 6.84% | -158.04% |
McKesson News
Returns for MCK
Cumulative Returns on MCK
13.9%
10-Year Cumulative Returns
15.9%
7-Year Cumulative Returns
28.4%
5-Year Cumulative Returns
44.6%
3-Year Cumulative Returns
Risks for MCK
What is the probability of a big loss on MCK?
33.1%
Probability that McKesson stock will be more than 20% underwater in next one year
10%
Probability that McKesson stock will be more than 30% underwater in next one year.
0%
Probability that McKesson stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does MCK drawdown profile look like?
Y-axis is the maximum loss one would have experienced if McKesson was unfortunately bought at previous high price.
Drawdowns
Financials for McKesson
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 2.6% | 284,040 | 276,711 | 273,903 | 272,027 | 268,446 | 263,966 | 257,006 | 250,991 | 245,223 | 238,228 | 237,621 | 234,194 | 231,002 | 231,051 | 224,945 | 221,981 | 217,440 | 214,319 | 213,518 | 210,927 | 209,913 |
| Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 202,565 | - | - | - |
| Gross Profit | 0.0% | 12,357 | 12,358 | 12,610 | 12,864 | 13,121 | 13,130 | 13,109 | 12,832 | 12,480 | 12,148 | 12,187 | 12,069 | 11,936 | 12,023 | 11,888 | 11,825 | 11,762 | 11,754 | 11,628 | 11,373 | 11,403 |
| Operating Expenses | -0.8% | 7,912 | 7,977 | 8,576 | 9,773 | 10,615 | 11,092 | 10,694 | 18,077 | 17,630 | 17,188 | 17,368 | 9,528 | 9,403 | 9,534 | 10,837 | 10,451 | 10,325 | 10,868 | 11,117 | 10,711 | 11,191 |
| S&GA Expenses | -1.1% | 7,687 | 7,776 | 8,343 | 9,545 | 10,264 | 10,537 | 10,230 | 9,416 | 8,984 | 8,849 | 8,833 | 8,668 | 8,388 | 9,182 | - | - | - | 8,437 | - | - | - |
| R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96.00 | - | - | - | 71.00 | - | - | - |
| EBITDA | -100.0% | - | 5,126 | 4,806 | 3,613 | 2,806 | 2,866 | 3,362 | -4,248 | -4,019 | -3,930 | -3,730 | 3,917 | 2,341 | 2,315 | 500 | 867 | 2,430 | 1,823 | 1,400 | 1,442 | 1,029 |
| EBITDA Margin | -100.0% | - | 0.02* | 0.02* | 0.01* | 0.01* | 0.01* | 0.01* | -0.02* | -0.02* | -0.02* | -0.02* | 0.02* | 0.01* | 0.01* | 0.00* | 0.00* | 0.01* | 0.01* | 0.01* | 0.01* | 0.00* |
| Interest Expenses | 0.8% | 250 | 248 | 212 | 184 | 174 | 178 | 187 | 201 | 206 | 217 | 210 | 200 | - | 249 | - | - | - | 264 | - | - | - |
| Earnings Before Taxes | 1.8% | 4,715 | 4,630 | 4,345 | 3,174 | 2,372 | 1,928 | 2,310 | -5,330 | -5,117 | -5,034 | -4,862 | 2,795 | 1,170 | 1,144 | -690 | -334 | 1,223 | 610 | 149 | 196 | -213 |
| EBT Margin | -100.0% | - | 0.02* | 0.02* | 0.01* | 0.01* | 0.01* | 0.01* | -0.02* | -0.02* | -0.02* | -0.02* | 0.01* | 0.01* | 0.00* | 0.00* | 0.00* | 0.01* | 0.00* | 0.00* | 0.00* | 0.00* |
| Net Income | 5.3% | 3,750 | 3,560 | 3,141 | 2,055 | 1,396 | 1,114 | 1,412 | -4,807 | -4,497 | -4,539 | -4,184 | 2,228 | 921 | 900 | -917 | -634 | 595 | 34.00 | -316 | 118 | -380 |
| Net Income Margin | -100.0% | - | 0.01* | 0.01* | 0.01* | 0.01* | 0.00* | 0.01* | -0.02* | -0.02* | -0.02* | -0.02* | 0.01* | 0.00* | 0.00* | 0.00* | 0.00* | 0.00* | 0.00* | 0.00* | 0.00* | 0.00* |
| Free Cashflow | -100.0% | - | 4,769 | 4,321 | 4,071 | 4,749 | 4,046 | 4,506 | 4,290 | 3,510 | 4,091 | 5,413 | 4,082 | 3,016 | 4,012 | 3,256 | 3,185 | 4,634 | 3,610 | 2,720 | 2,905 | 2,112 |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 2.8% | 64,096 | 62,320 | 62,690 | 63,081 | 62,295 | 63,298 | 63,708 | 63,601 | 62,894 | 65,015 | 61,845 | 61,558 | 57,666 | 61,247 | 60,873 | 58,994 | 61,680 | 59,672 | 61,011 | 61,421 | 61,282 |
| Current Assets | 2.8% | 45,539 | 44,292 | 44,657 | 46,448 | 45,383 | 46,231 | 46,498 | 45,580 | 43,350 | 45,382 | 42,368 | 42,345 | 38,682 | 42,222 | 39,390 | 37,353 | 38,428 | 38,465 | 38,319 | 38,544 | 38,214 |
| Cash Equivalents | -43.7% | 2,636 | 4,678 | 2,774 | 2,916 | 2,233 | 3,935 | 2,754 | 2,151 | 2,423 | 6,278 | 3,577 | 3,091 | 2,613 | 4,023 | 2,065 | 1,356 | 1,947 | 2,981 | 1,849 | 2,118 | 2,199 |
| Inventory | 4.2% | 20,510 | 19,691 | 20,657 | 19,876 | 19,505 | 18,702 | 19,024 | 19,342 | 20,016 | 19,200 | 19,211 | 18,435 | 16,607 | 16,734 | 17,020 | 16,356 | 16,604 | 16,709 | 16,951 | 16,671 | 16,364 |
| Net PPE | -0.2% | 2,172 | 2,177 | 2,140 | 2,071 | 2,083 | 2,092 | 2,064 | 2,222 | 2,549 | 2,581 | 2,518 | 2,471 | 2,392 | 2,365 | 2,408 | 2,493 | 2,466 | 2,548 | 2,503 | 2,488 | 2,483 |
| Goodwill | 0.2% | 9,971 | 9,947 | 9,934 | 9,239 | 9,368 | 9,451 | 9,462 | 9,473 | 9,520 | 9,493 | 9,511 | 9,414 | 9,419 | 9,360 | 9,456 | 9,408 | 388 | 9,358 | 386 | 246 | 10,585 |
| Current Liabilities | 1.0% | 48,422 | 47,957 | 48,006 | 48,357 | 47,201 | 48,466 | 47,452 | 46,075 | 43,835 | 44,103 | 41,930 | 42,724 | 38,600 | 42,624 | 40,055 | 37,145 | 37,952 | 37,626 | 37,424 | 38,863 | 38,348 |
| Short Term Borrowings | - | - | - | 617 | - | - | - | 372 | - | - | - | 152 | - | - | - | 2,109 | 549 | - | - | 1,048 | 1,394 | 2,033 |
| Long Term Debt | 21.3% | 5,611 | 4,626 | 5,452 | 4,813 | 4,976 | 5,080 | - | - | 6,424 | 6,406 | 6,467 | - | - | 6,335 | - | - | - | 7,265 | - | - | - |
| LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | 1,760 | 1,053 | 1,052 | 1,007 | 302 | 310 | 330 | 1,120 | 1,126 | 1,127 |
| LT Debt, Non Current | - | - | - | - | - | - | - | 5,518 | 5,946 | - | 6,406 | - | 5,848 | 6,395 | 6,335 | 6,734 | 7,342 | 7,382 | 7,265 | 7,616 | 6,568 | 6,592 |
| Shareholder's Equity | - | - | - | - | - | - | - | - | - | - | 175 | - | 6,090 | 5,653 | 5,309 | 6,385 | 6,692 | 8,068 | 8,287 | 9,389 | 9,534 | 9,647 |
| Retained Earnings | 7.2% | 13,182 | 12,295 | 11,582 | 10,579 | 9,732 | 9,030 | 8,734 | 8,812 | 8,618 | 8,202 | 7,595 | 13,890 | 13,384 | 13,022 | 12,075 | 11,965 | 12,770 | 12,409 | 13,276 | 13,354 | 12,932 |
| Additional Paid-In Capital | 1.0% | 7,824 | 7,747 | 7,536 | 7,609 | 7,350 | 7,275 | 7,411 | 7,311 | 7,057 | 6,925 | 6,847 | 6,780 | 6,711 | 6,663 | 6,614 | 6,573 | 6,483 | 6,435 | 6,321 | 6,411 | 6,372 |
| Shares Outstanding | - | 136 | - | 140 | 143 | 144 | - | 152 | 154 | 156 | - | 160 | 162 | 162 | - | 179 | 183 | 188 | - | 194 | 198 | 202 |
| Minority Interest | -1.4% | 362 | 367 | 366 | 518 | 532 | 480 | 487 | 484 | 484 | 196 | 200 | 200 | 207 | 217 | 211 | 210 | 194 | 193 | 204 | 208 | 240 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -2.2% | 5,048 | 5,159 | 4,721 | 4,430 | 5,115 | 4,434 | 4,917 | 4,753 | 3,982 | 4,542 | 5,826 | 4,492 | 3,363 | 4,374 | 3,615 | 3,559 | 5,046 | 4,036 | 3,165 | 3,324 | 2,543 |
| Cashflow From Investing | -34.7% | -730 | -542 | -115 | 184 | 49.00 | -89.00 | -477 | -294 | -384 | -415 | -380 | -572 | -580 | -579 | -639 | -683 | -635 | -1,381 | -2,192 | -2,111 | -2,270 |
| Cashflow From Financing | 7.7% | -4,030 | -4,368 | -5,167 | -4,180 | -5,351 | -6,321 | -4,849 | -5,186 | -3,905 | -1,693 | -3,656 | -1,932 | -1,801 | -2,734 | -2,798 | -3,628 | -4,640 | -2,227 | -1,620 | -1,614 | -412 |
| Dividend Payments | 1.0% | 295 | 292 | 287 | 282 | 279 | 277 | 273 | 270 | 271 | 276 | 281 | 286 | 293 | 294 | 298 | 301 | 296 | 292 | 286 | 280 | 271 |
| Buy Backs | -8.4% | 3,334 | 3,638 | 5,030 | 3,782 | 3,538 | 3,516 | 2,258 | 1,761 | 1,750 | 742 | 483 | 752 | 1,233 | 1,934 | 2,202 | 2,202 | 2,032 | 1,639 | 2,145 | 1,895 | 1,716 |
MCK Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||
| Revenues | $ 74,483 | $ 67,154 |
| Cost of sales | (71,461) | (64,131) |
| Gross profit | 3,022 | 3,023 |
| Selling, distribution, general, and administrative expenses | (1,870) | (1,959) |
| Claims and litigation charges, net | 0 | (5) |
| Restructuring, impairment, and related charges, net | (52) | (23) |
| Total operating expenses | (1,922) | (1,987) |
| Operating income | 1,100 | 1,036 |
| Other income, net | 38 | 15 |
| Interest expense | (47) | (45) |
| Income from continuing operations before income taxes | 1,091 | 1,006 |
| Income tax expense | (94) | (199) |
| Income from continuing operations | 997 | 807 |
| Income from discontinued operations, net of tax | 0 | 2 |
| Net income | 997 | 809 |
| Net income attributable to noncontrolling interests | (39) | (41) |
| Net income attributable to McKesson Corporation | $ 958 | $ 768 |
| Diluted | ||
| Continuing operations (in usd per share) | $ 7.02 | $ 5.25 |
| Discontinued operations (in usd per share) | 0 | 0.01 |
| Total (in dollars per share) | 7.02 | 5.26 |
| Basic | ||
| Continuing operations (in usd per share) | 7.07 | 5.31 |
| Discontinued operations (in usd per share) | 0 | 0.01 |
| Total (in dollars per share) | $ 7.07 | $ 5.32 |
| Weighted-average common shares outstanding | ||
| Diluted (in usd per share) | 136.6 | 145.9 |
| Basic (in shares) | 135.5 | 144.2 |
MCK Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Jun. 30, 2023 | Mar. 31, 2023 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $ 2,636 | $ 4,678 |
| Receivables, net | 21,860 | 19,410 |
| Inventories, net | 20,510 | 19,691 |
| Prepaid expenses and other | 533 | 513 |
| Total current assets | 45,539 | 44,292 |
| Property, plant, and equipment, net | 2,172 | 2,177 |
| Operating lease right-of-use assets | 1,693 | 1,635 |
| Goodwill | 9,971 | 9,947 |
| Intangible assets, net | 2,221 | 2,277 |
| Other non-current assets | 2,500 | 1,992 |
| Total assets | 64,096 | 62,320 |
| Current liabilities | ||
| Drafts and accounts payable | 43,982 | 42,490 |
| Current portion of long-term debt | 50 | 968 |
| Current portion of operating lease liabilities | 300 | 299 |
| Other accrued liabilities | 4,090 | 4,200 |
| Total current liabilities | 48,422 | 47,957 |
| Long-term debt | 5,611 | 4,626 |
| Long-term deferred tax liabilities | 1,139 | 1,387 |
| Long-term operating lease liabilities | 1,462 | 1,402 |
| Long-term litigation liabilities | 6,628 | 6,625 |
| Other non-current liabilities | 2,074 | 1,813 |
| McKesson Corporation stockholders’ deficit | ||
| Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding | 0 | 0 |
| Common stock, $0.01 par value, 800 shares authorized, 278 and 277 shares issued at June 30, 2023 and March 31, 2023, respectively | 3 | 3 |
| Additional paid-in capital | 7,824 | 7,747 |
| Retained earnings | 13,182 | 12,295 |
| Accumulated other comprehensive loss | (848) | (905) |
| Treasury shares, at cost, 143 and 141 shares at June 30, 2023 and March 31, 2023, respectively | (21,763) | (20,997) |
| Total McKesson Corporation stockholders’ deficit | (1,602) | (1,857) |
| Noncontrolling interests | 362 | 367 |
| Total deficit | (1,240) | (1,490) |
| Total liabilities and deficit | $ 64,096 | $ 62,320 |
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.